Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1940-0640
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial ; volume:16 ; number:1 ; day:12 ; month:2 ; year:2021 ; pages:1-10 ; date:12.2021
Addiction science & clinical practice ; 16, Heft 1 (12.2.2021), 1-10, 12.2021
- Urheber
-
Wong, James S. H.
Nikoo, Mohammadali
Westenberg, Jean N.
Suen, Janet G.
Wong, Jennifer Y. C.
Krausz, Reinhard M.
Schütz, Christian G.
Vogel, Marc
Sidhu, Jesse A.
Moe, Jessica
Arishenkoff, Shane
Griesdale, Donald
Mathew, Nickie
Azar, Pouya
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-021-00220-2
- URN
-
urn:nbn:de:101:1-2021040314341503753768
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wong, James S. H.
- Nikoo, Mohammadali
- Westenberg, Jean N.
- Suen, Janet G.
- Wong, Jennifer Y. C.
- Krausz, Reinhard M.
- Schütz, Christian G.
- Vogel, Marc
- Sidhu, Jesse A.
- Moe, Jessica
- Arishenkoff, Shane
- Griesdale, Donald
- Mathew, Nickie
- Azar, Pouya
- SpringerLink (Online service)
Ähnliche Objekte (12)
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Buprenorphine unobserved “home” induction: a survey of Ontario’s addiction physicians
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
Induction
Induction
Induction
Induction
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Buprenorphine unobserved “home” induction: a survey of Ontario’s addiction physicians
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
Induction
Induction
Induction
Induction
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Buprenorphine unobserved “home” induction: a survey of Ontario’s addiction physicians
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
Induction
Induction
Induction